Omeros reported $12.2M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 5.26M 1.56M
Adma Biologics ADMA:US USD 17.75M 1.86M
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Cytokinetics CYTK:US USD 48.22M 5.51M
Dynavax Technologies DVAX:US USD 32.04M 3.69M
Gilead Sciences GILD:US USD 2.02B 807M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Insmed INSM:US USD 75.58M 15.61M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Knight Therapeutics Inc GUD:CN CAD 23.87M 2.38M
Macrogenics MGNX:US USD 15.35M 1.69M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Omeros OMER:US USD 12.2M 1.72M
Pacira Pharmaceuticals PCRX:US USD 61.28M 3.72M
Pfizer PFE:US USD 4.87B 1.33B
Regulus Therapeutics RGLS:US USD 2.25M 214K
Rockwell Medical RMTI:US USD 4.02M 1.28M
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
United Therapeutics UTHR:US USD 98.4M 43.1M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
Vital Therapies VTL:US USD 3.58M 493K
Xoma XOMA:US USD 4.79M 916K